Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Law channel feed
J&J faces South African competition probe over high tuberculosis drug prices
Last year
Pharma
HHS says Merck's interpretations of IRA 'doom' its legal challenge
Last year
Pharma
FDA+
White House warns over lackluster FDA funding increase in incoming appropriations bill
Last year
FDA+
DOJ and Danco Laboratories petition Supreme Court over mifepristone restrictions
Last year
Pharma
Kroger inks $1.4B settlement deal for opioid lawsuits
Last year
Pharma
New bipartisan House bill includes major PBM reforms
Last year
Pharma
Bristol Myers Squibb and Celgene named in class action suit over cancer blockbuster Pomalyst
Last year
Pharma
iPSC biotech Shoreline Biosciences wins patent infringement suit over Fate, Whitehead Institute
Last year
Pharma
Cell/Gene Tx
Court agrees with AbbVie’s methodology for damages in Takeda case
Last year
Pharma
'FDA is not a physician,' appeals court rules in case against agency's ivermectin messaging
Last year
Pharma
FDA+
Novartis sues over IRA ahead of Entresto price negotiations
Last year
Pharma
Legal experts say some IRA challenges are 'weaker than others'
Last year
Pharma
Alkermes, Teva settle patent suit around opioid-blocker Vivitrol, paving way for generics after three-year fight
Last year
Pharma
Here's how pharma companies might remove their products from price negotiation
Last year
Pfizer challenges Moderna Covid vaccine patents before Patent Trial and Appeal Board
Last year
Pharma
DC appeals court dismisses FTC case against Endo and Impax's opioid agreement
Last year
Alnylam plans to appeal Covid-19 vaccine patent ruling in case against Moderna
Last year
Pharma
FTC pauses challenge of Amgen's $28B Horizon takeover to consider settlement
Last year
Pharma
AstraZeneca disputes IRA’s orphan drug provisions in latest legal challenge to the law
Last year
Pharma
FDA+
CA federal judge allows former employee's case against SomaLogic to continue
Last year
Pharma
US Patent and Trademark Office to hear patent challenge over experimental seizure treatment
Last year
Pharma
Alkermes' $194M payment from Janssen gets approval from court
Last year
Pharma
Ex-employees of Ramaswamy's investment company sue, claiming they were misled or pushed to violate securities law
Last year
People
DOJ plans to take mifepristone challenge to the Supreme Court
Last year
Pharma
FDA+
First page
Previous page
16
17
18
19
20
21
22
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit